Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT00371982
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
1. whether the intake of n-3 PUFA has additional effects on insulin sensitivity and adiposity (total fat mass and adipocyte morphology and function) in T2D women.
2. n-3 PUFA supplementation might influence inflammatory genes expression in the adipose tissue of T2D patients.
- Detailed Description
Thus, the present study was designed to evaluate the effects of n-3 PUFAs dietary supplementation on lipid and glucose homeostasis and to address the impact of this treatment on adiposity and adipose tissue gene expression in T2D women.A total of 27 T2D women (BMI 27-35kg/m², age 40-60 y) were randomly allocated to two months of 3 g/day of either fish oil (1.8 g n-3 PUFA) or placebo (paraffin oil), in a double-blind parallel design.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 24
- Type 2 diabetic postmenopausal women
- glycaemia of 7.87-14.0 mmol/l, HbA1c of 7 to 10.5%
- plasma triglycerides between 1.72-4.6 mmol/l,
- aged between 40 -60,
- BMI: 27-40 kg/m2
- able to swallow tablets
- patients with abnormal renal, hepatic and thyroid functions as determined by physical examination, blood cell count and standard blood biochemical profile
- patients with gastrointestinal disorders
- patients treated with thiazolidinediones or insulin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The effect of 2 month treatment on: adiposity (total fat mass, adipocyte morphology), atherogenic markers and insulin sensitivity
- Secondary Outcome Measures
Name Time Method the underlying mechanisms of the observed results and tried to define new targets of fish oil metabolic effects and the impact of fish oil on systemic inflammatory markers and adipose tissue inflammatory genes.
Trial Locations
- Locations (1)
Department of Diabetes-Hotel Dieu Hospital
🇫🇷Paris, France